Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20181208041882N15Phase 3Completed
Phase 3 trial of pregabalin in diabetic neuropathy (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Intensity of neuropathic pain. Started Jun 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20181208041882N15.